Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate panel appropriates $2.04 billion for FDA

This article was originally published in The Gray Sheet

Executive Summary

FDA will have $2.04 billion in appropriations for fiscal 2009, including $278.4 million for the device center and related field activities, under an Agriculture bill that passed the Senate Appropriations Committee July 17. The bill would give FDA $324.6 million more than it received this year, and $5.2 million more than the Bush administration's request. CDRH would gain $40.4 million more in FY 2009 appropriations over fiscal '08, and $1 million more than the president requested. The bill anticipates $52.5 million in device user fee funding for FY 2009. With the expanded FDA funding, the committee wants $104 million spent for device, drug and biologic safety to increase overseas and domestic inspections and $40 million to upgrade science programs across the agency. The House Appropriations Committee has yet to sign off on funding levels, and Chairman David Obey, D-Wis., previously suggested resorting to continuing resolutions 1("The Gray Sheet" July 7, 2008, p. 9)
Advertisement

Related Content

FY 2009 FDA Appropriations Will Likely Have To Wait For Next Administration
FY 2009 FDA Appropriations Will Likely Have To Wait For Next Administration
Advertisement
UsernamePublicRestriction

Register

MT026361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel